FDA Webview
X

Free FDA Notices

Review Period Set for X-Stop Interspinous System

06/01/2007

Federal Register Notice: FDA has determined the regulatory review period for St. Francis Medical Technologies, Inc.’s X-Stop Interspinous Process Decompression System is 2,224 days for extending a patent which claims that medical device. The system is indicated for treating patients aged 50 or older suffering from neurogenic intermittent claudication secondary to a confirmed diagnosis of lumbar spinal stenosis (with x-ray, magnetic resonance imaging (MRI), and/or computerized tomography evidence of thickened ligamentum flavum, narrowed lateral recess and/or central canal narrowing). To view this notice, click here.

LATEST NEWS